Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 5/2020

01-05-2020 | Obesity | Review

Legend of Weight Loss: a Crosstalk Between the Bariatric Surgery and the Brain

Authors: Ziwei Lin, Shen Qu

Published in: Obesity Surgery | Issue 5/2020

Login to get access

Abstract

In recent years, plenty of researches have reported in obese individuals with abnormal brain processes implicated in homeostatic regulation, reward, emotion, memory, attention, and executive function in eating behaviors. Thus, treating obesity cannot remain “brainless.” Behavioral and psychological interventions activate the food reward, attention, and motivation system, leading to minimal weight loss and high relapse rates. Pharmacotherapy is an effective weight loss method and regulate brain activity but with concerns about its brain function safety problems. Obesity surgery, the most effective therapy currently available for obesity, shows pronounced effects on brain activity, such as deactivation of reward and attention system, and activation of inhibition control toward food cues. In this review, we present an overview of alterations in the brain after the three common weight loss methods.
Literature
1.
Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc. 2007 Oct;107(10):1755–67.PubMedCrossRef
2.
Wolfenden L, Ezzati M, Larijani B, et al. The challenge for global health systems in preventing and managing obesity. Obes Rev. 2019;
3.
Reilly JJ, Hughes AR, Gillespie J, et al. Physical activity interventions in early life aimed at reducing later risk of obesity and related non-communicable diseases: a rapid review of systematic reviews. Obes Rev. 2019;20(Suppl 1):61–73.PubMedCrossRef
4.
Murdaugh DL, Cox JE, Cook 3rd EW, et al. fMRI reactivity to high-calorie food pictures predicts short- and long-term outcome in a weight-loss program. NeuroImage. 2012;59(3):2709–21.PubMedCrossRef
5.
Fuentes Artiles R, Staub K, Aldakak L, et al. Mindful eating and common diet programs lower body weight similarly: systematic review and meta-analysis. Obes Rev. 2019;1
6.
Krentz AJ, Fujioka K, Hompesch M. Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles. Diabetes Obes Metab. 2016 Jun;18(6):558–70.PubMedCrossRef
7.
Sjostrom L. Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219–34.CrossRefPubMed
8.
Mikkelsen KH, Allin KH, Knop FK. Effect of antibiotics on gut microbiota, glucose metabolism and body weight regulation: a review of the literature. Diabetes Obes Metab. 2016;18(5):444–53. Epub 2016/01/29PubMedCrossRef
9.
Yao J, He Z, Chen Y, et al. Acupuncture and weight loss in Asians: a PRISMA-compliant systematic review and meta-analysis. Medicine. 2019;98(33):e16815.PubMedPubMedCentralCrossRef
10.
11.
Stice E, Burger K, Yokum S. Caloric deprivation increases responsivity of attention and reward brain regions to intake, anticipated intake, and images of palatable foods. NeuroImage. 2013;67:322–30.PubMedCrossRef
12.
13.
Baboumian S, Pantazatos SP, Kothari S, et al. Functional magnetic resonance imaging (fMRI) neural responses to visual and auditory food stimuli pre and post Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). Neuroscience. 2019;12
14.
O'Brien PE, McPhail T, Chaston TB, et al. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16(8):1032–40.PubMedCrossRef
15.
16.
17.
Choudhury AI, Heffron H, Smith MA, et al. The role of insulin receptor substrate 2 in hypothalamic and beta cell function. J Clin Invest. 2005;115(4):940–50.PubMedPubMedCentralCrossRef
18.
Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411(6836):480–4.PubMedCrossRef
19.
Zigman JM, Bouret SG, Andrews ZB. Obesity impairs the action of the neuroendocrine ghrelin system. Trends Endocrinol Metab. 2016;27(1):54–63.PubMedCrossRef
20.
Maniscalco JW, Zheng H, Gordon PJ, et al. Negative energy balance blocks neural and behavioral responses to acute stress by “silencing” central glucagon-like peptide 1 signaling in rats. J Neurosci. 2015;35(30):10701–14.PubMedPubMedCentralCrossRef
21.
van Bloemendaal L, Veltman DJ, ten Kulve JS, et al. Emotional eating is associated with increased brain responses to food-cues and reduced sensitivity to GLP-1 receptor activation. Obesity (Silver Spring). 2015;23(10):2075–82.CrossRef
22.
Skow MA, Bergmann NC, Knop FK. Diabetes and obesity treatment based on dual incretin receptor activation: ‘twincretins’. Diabetes Obes Metab. 2016;18(9):847–54.PubMedCrossRef
23.
Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319–26.PubMedCrossRef
24.
Bostrom PA, Fernandez-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metabolism. 2014;63(2):178–80.PubMedCrossRef
25.
Garcia-Garcia I, Horstmann A, Jurado MA, et al. Reward processing in obesity, substance addiction and non-substance addiction. Obes Rev. 2014;15(11):853–69.PubMedCrossRef
26.
DiLeone RJ, Taylor JR, Picciotto MR. The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addiction. Nat Neurosci. 2012;15(10):1330–5.PubMedPubMedCentralCrossRef
27.
Ziauddeen H, Alonso-Alonso M, Hill JO, et al. Obesity and the neurocognitive basis of food reward and the control of intake. Adv Nutr. 2015;6(4):474–86.PubMedPubMedCentralCrossRef
28.
Volkow ND, Wang GJ, Tomasi D, et al. Obesity and addiction: neurobiological overlaps. Obes Rev. 2013;14(1):2–18.PubMedCrossRef
29.
Stice E, Spoor S, Bohon C, et al. Relation of reward from food intake and anticipated food intake to obesity: a functional magnetic resonance imaging study. J Abnorm Psychol. 2008;117(4):924–35.PubMedPubMedCentralCrossRef
30.
Stice E, Yokum S, Bohon C, et al. Reward circuitry responsivity to food predicts future increases in body mass: moderating effects of DRD2 and DRD4. NeuroImage. 2010;50(4):1618–25.PubMedCrossRef
31.
32.
Volkow ND, Wang GJ, Telang F, et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. NeuroImage. 2008;42(4):1537–43.PubMedCrossRef
33.
Gluck ME, Viswanath P, Stinson EJ. Obesity, appetite, and the prefrontal cortex. Curr Obes Rep. 2017;6(4):380–8.PubMedCrossRef
34.
Kullmann S, Heni M, Veit R, et al. Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults. Diabetes Care. 2015;38(6):1044–50.PubMedCrossRef
35.
Reyes S, Peirano P, Peigneux P, et al. Inhibitory control in otherwise healthy overweight 10-year-old children. Int J Obes. 2015;39(8):1230–5.CrossRef
36.
Levitan RD, Rivera J, Silveira PP, et al. Gender differences in the association between stop-signal reaction times, body mass indices and/or spontaneous food intake in pre-school children: an early model of compromised inhibitory control and obesity. Int J Obes. 2015;39(4):614–9.CrossRef
37.
Nederkoorn C, Jansen E, Mulkens S, et al. Impulsivity predicts treatment outcome in obese children. Behav Res Ther. 2007;45(5):1071–5.PubMedCrossRef
38.
Doolan KJ, Breslin G, Hanna D, et al. Attentional bias to food-related visual cues: is there a role in obesity? Proc Nutr Soc. 2015;74(1):37–45.PubMedCrossRef
39.
40.
O'Doherty JP, Deichmann R, Critchley HD, et al. Neural responses during anticipation of a primary taste reward. Neuron. 2002;33(5):815–26.PubMedCrossRef
41.
Mehta S, Melhorn SJ, Smeraglio A, et al. Regional brain response to visual food cues is a marker of satiety that predicts food choice. Am J Clin Nutr. 2012;96(5):989–99.PubMedPubMedCentralCrossRef
42.
Wang GJ, Yang J, Volkow ND, et al. Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry. Proc Natl Acad Sci U S A. 2006;103(42):15641–5.PubMedPubMedCentralCrossRef
43.
Martin AA, Davidson TL. Human cognitive function and the obesogenic environment. Physiol Behav. 2014;136:185–93.PubMedCrossRef
44.
Parent MB, Darling JN, Henderson YO. Remembering to eat: hippocampal regulation of meal onset. Am J Physiol Regul Integr Comp Physiol. 2014;306(10):R701–13.PubMedPubMedCentralCrossRef
45.
46.
Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122(1):153–62.PubMedCrossRef
47.
Prada PO, Zecchin HG, Gasparetti AL, et al. Western diet modulates insulin signaling, c-Jun N-terminal kinase activity, and insulin receptor substrate-1ser307 phosphorylation in a tissue-specific fashion. Endocrinology. 2005;146(3):1576–87.PubMedCrossRef
48.
De Souza CT, Araujo EP, Bordin S, et al. Consumption of a fat-rich diet activates a proinflammatory response and induces insulin resistance in the hypothalamus. Endocrinology. 2005;146(10):4192–9.PubMedCrossRef
49.
Clegg DJ, Gotoh K, Kemp C, et al. Consumption of a high-fat diet induces central insulin resistance independent of adiposity. Physiol Behav. 2011;103(1):10–6.PubMedPubMedCentralCrossRef
50.
51.
Romanatto T, Cesquini M, Amaral ME, et al. TNF-alpha acts in the hypothalamus inhibiting food intake and increasing the respiratory quotient--effects on leptin and insulin signaling pathways. Peptides. 2007;28(5):1050–8.PubMedCrossRef
52.
Li J, Tang Y, Cai D. IKKbeta/NF-kappaB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes. Nat Cell Biol. 2012;14(10):999–1012.PubMedPubMedCentralCrossRef
53.
54.
Andre C, Dinel AL, Ferreira G, et al. Diet-induced obesity progressively alters cognition, anxiety-like behavior and lipopolysaccharide-induced depressive-like behavior: focus on brain indoleamine 2,3-dioxygenase activation. Brain Behav Immun. 2014;41:10–21.PubMedCrossRef
55.
Sobesky JL, Barrientos RM, De May HS, et al. High-fat diet consumption disrupts memory and primes elevations in hippocampal IL-1beta, an effect that can be prevented with dietary reversal or IL-1 receptor antagonism. Brain Behav Immun. 2014;42:22–32.PubMedPubMedCentralCrossRef
56.
Paolicelli RC, Bolasco G, Pagani F, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011 Sep 9;333(6048):1456–8.PubMedCrossRef
57.
58.
59.
Rhea EM, Salameh TS, Logsdon AF, et al. Blood-brain barriers in obesity. AAPS J. 2017;19(4):921–30.PubMedCrossRef
60.
Ouyang S, Hsuchou H, Kastin AJ, et al. Diet-induced obesity suppresses expression of many proteins at the blood-brain barrier. J Cereb Blood Flow Metab. 2014;34(1):43–51.PubMedCrossRef
61.
62.
Andela S, Burrows TL, Baur LA, et al. Efficacy of very low-energy diet programs for weight loss: a systematic review with meta-analysis of intervention studies in children and adolescents with obesity. Obes Rev. 2019;20(6):871–82.PubMedCrossRef
63.
Astbury NM, Piernas C, Hartmann-Boyce J, et al. A systematic review and meta-analysis of the effectiveness of meal replacements for weight loss. Obes Rev. 2019;20(4):569–87.PubMedPubMedCentralCrossRef
64.
Yen HY, Chiu HL. The effectiveness of wearable technologies as physical activity interventions in weight control: a systematic review and meta-analysis of randomized controlled trials. Obes Rev. 2019;20(10):1485–93.PubMedCrossRef
65.
Seo YG, Noh HM, Kim SY. Weight loss effects of circuit training interventions: a systematic review and meta-analysis. Obes Rev. 2019;19
66.
Yang Y, Shields GS, Wu Q, et al. Cognitive training on eating behaviour and weight loss: a meta-analysis and systematic review. Obes Rev. 2019;28
67.
Prehn K, Jumpertz von Schwartzenberg R, Mai K, et al. Caloric restriction in older adults-differential effects of weight loss and reduced weight on brain structure and function. Cereb Cortex. 2017;27(3):1765–78.PubMed
68.
Michel S, Raab R, Drabsch T, et al. Do lifestyle interventions during pregnancy have the potential to reduce long-term postpartum weight retention? A systematic review and meta-analysis. Obes Rev. 2019;20(4):527–42.PubMed
69.
Neumark-Sztainer D, Wall M, Guo J, et al. Obesity, disordered eating, and eating disorders in a longitudinal study of adolescents: how do dieters fare 5 years later? J Am Diet Assoc. 2006;106(4):559–68.PubMedCrossRef
70.
Stice E, Davis K, Miller NP, et al. Fasting increases risk for onset of binge eating and bulimic pathology: a 5-year prospective study. J Abnorm Psychol. 2008;117(4):941–6.PubMedPubMedCentralCrossRef
71.
Doucet E, McInis K, Mahmoodianfard S. Compensation in response to energy deficits induced by exercise or diet. Obes Rev. 2018;19(Suppl 1):36–46.PubMedCrossRef
72.
Fuhrer D, Zysset S, Stumvoll M. Brain activity in hunger and satiety: an exploratory visually stimulated FMRI study. Obesity (Silver Spring). 2008;16(5):945–50.CrossRef
73.
Leidy HJ, Lepping RJ, Savage CR, et al. Neural responses to visual food stimuli after a normal vs. higher protein breakfast in breakfast-skipping teens: a pilot fMRI study. Obesity (Silver Spring). 2011;19(10):2019–25.CrossRef
74.
Goldstone AP, Prechtl de Hernandez CG, Beaver JD, et al. Fasting biases brain reward systems towards high-calorie foods. Eur J Neurosci. 2009;30(8):1625–35.PubMedCrossRef
75.
McDermott KD, Williams SE, Espeland MA, et al. Impact of intensive lifestyle intervention on neural food cue reactivity: action for health in diabetes brain ancillary study. Obesity (Silver Spring). 2019;27(7):1076–84.PubMedCentral
76.
Dong Z, Xu L, Liu H, et al. Comparative efficacy of five long-term weight loss drugs: quantitative information for medication guidelines. Obes Rev. 2017;18(12):1377–85.PubMedCrossRef
77.
Farr OM, Sofopoulos M, Tsoukas MA, et al. GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial. Diabetologia. 2016;59(5):954–65.PubMedPubMedCentralCrossRef
78.
van Bloemendaal L, Ten Kulve JS, la Fleur SE, et al. Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS. J Endocrinol. 2014;221(1):T1–16.PubMedCrossRef
79.
Wadden TA, Hollander P, Klein S, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study. Int J Obes. 2013;37(11):1443–51.CrossRef
80.
Davies MJ, Bergenstal R, Bode B, et al. Efficacy of Liraglutide for weight loss among patients with type 2 diabetes: the SCALE diabetes randomized clinical trial. JAMA. 2015;314(7):687–99.PubMedCrossRef
81.
Greenway FL, Fujioka K, Plodkowski RA, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.PubMedCrossRef
82.
Apovian CM, Aronne L, Rubino D, et al. A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity (Silver Spring). 2013;21(5):935–43.CrossRef
83.
Wadden TA, Foreyt JP, Foster GD, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011;19(1):110–20.CrossRef
84.
Hollander P, Gupta AK, Plodkowski R, et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.PubMedPubMedCentralCrossRef
85.
Wang GJ, Tomasi D, Volkow ND, et al. Effect of combined naltrexone and bupropion therapy on the brain's reactivity to food cues. Int J Obes. 2014;38(5):682–8.CrossRef
86.
Roth BL, Willins DL, Kristiansen K, et al. 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function. Pharmacol Ther. 1998;79(3):231–57.CrossRefPubMed
87.
Smith SR, Weissman NJ, Anderson CM, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.CrossRefPubMed
88.
Fidler MC, Sanchez M, Raether B, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011 Oct;96(10):3067–77.CrossRefPubMed
89.
O'Neil PM, Smith SR, Weissman NJ, et al. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012;20(7):1426–36.CrossRef
90.
Farr OM, Upadhyay J, Gavrieli A, et al. Lorcaserin administration decreases activation of brain centers in response to food cues and these emotion- and salience-related changes correlate with weight loss effects: a 4-week-long randomized, placebo-controlled, double-blind clinical trial. Diabetes. 2016;65(10):2943–53.PubMedPubMedCentralCrossRef
91.
Colman E. Food and Drug Administration's obesity drug guidance document: a short history. Circulation. 2012;125(17):2156–64.PubMedCrossRef
92.
Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307(1):56–65.PubMedCrossRef
93.
Zhu C, Mei F, Gao J, et al. Changes in inflammatory markers correlated with increased testosterone after laparoscopic sleeve gastrectomy in obese Chinese men with acanthosis nigricans. J Dermatol. 2019;46(4):338–42.PubMedCrossRef
94.
Zhang Y, Zhu C, Wen X, et al. Laparoscopic sleeve gastrectomy improves body composition and alleviates insulin resistance in obesity related acanthosis nigricans. Lipids Health Dis. 2017;16(1):209.PubMedPubMedCentralCrossRef
95.
Gao J, Zhang M, Zhu C, et al. The change in the percent of android and gynoid fat mass correlated with increased testosterone after laparoscopic sleeve gastrectomy in Chinese obese men: a 6-month follow-up. Obes Surg. 2018;28(7):1960–5.PubMedCrossRef
96.
Cardoso L, Rodrigues D, Gomes L, et al. Short- and long-term mortality after bariatric surgery: a systematic review and meta-analysis. Diabetes Obes Metab. 2017;19(9):1223–32.PubMedCrossRef
97.
Yeo C, Kaushal S, Lim B, et al. Impact of bariatric surgery on serum uric acid levels and the incidence of gout-A meta-analysis. Obes Rev. 2019;
98.
Hansen TT, Jakobsen TA, Nielsen MS, et al. Hedonic changes in food choices following Roux-en-Y gastric bypass. Obes Surg. 2016;26(8):1946–55.PubMedCrossRef
99.
Gero D, Dib F, Ribeiro-Parenti L, et al. Desire for Core tastes decreases after sleeve Gastrectomy: a single-center longitudinal observational study with 6-month follow-up. Obes Surg. 2017;27(11):2919–26.PubMedCrossRef
100.
Alosco ML, Galioto R, Spitznagel MB, et al. Cognitive function after bariatric surgery: evidence for improvement 3 years after surgery. Am J Surg. 2014;207(6):870–6.PubMedCrossRef
101.
Behary P, Miras AD. Food preferences and underlying mechanisms after bariatric surgery. Proc Nutr Soc. 2015;74(4):419–25.PubMedCrossRef
102.
Ochner CN, Kwok Y, Conceicao E, et al. Selective reduction in neural responses to high calorie foods following gastric bypass surgery. Ann Surg. 2011;253(3):502–7.PubMedCrossRef
103.
Zoon HFA, de Bruijn SEM, Smeets PAM, et al. Altered neural responsivity to food cues in relation to food preferences, but not appetite-related hormone concentrations after RYGB-surgery. Behav Brain Res. 2018;353:194–202.PubMedCrossRef
104.
Scholtz S, Miras AD, Chhina N, et al. Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut. 2014;63(6):891–902.PubMedCrossRef
105.
Frank S, Wilms B, Veit R, et al. Altered brain activity in severely obese women may recover after Roux-en Y gastric bypass surgery. Int J Obes. 2014;38(3):341–8.CrossRef
106.
Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes - 5-year outcomes. N Engl J Med. 2017;376(7):641–51.PubMedPubMedCentralCrossRef
107.
Panagiotou OA, Markozannes G, Adam GP, et al. Comparative effectiveness and safety of bariatric procedures in Medicare-eligible patients: a systematic review. JAMA Surg. 2018;153(11):e183326.PubMedCrossRef
108.
Li G, Ji G, Hu Y, et al. Reduced plasma ghrelin concentrations are associated with decreased brain reactivity to food cues after laparoscopic sleeve gastrectomy. Psychoneuroendocrinology. 2019;100:229–36.PubMedCrossRef
109.
Bruce JM, Hancock L, Bruce A, et al. Changes in brain activation to food pictures after adjustable gastric banding. Surg Obes Relat Dis. 2012;8(5):602–8.PubMedCrossRef
110.
Mauro M, Papelbaum M, Brasil MAA, et al. Is weight regain after bariatric surgery associated with psychiatric comorbidity? A systematic review and meta-analysis. Obes Rev. 2019;20(10):1413–25.PubMedCrossRef
111.
Goldman RL, Canterberry M, Borckardt JJ, et al. Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity (Silver Spring). 2013;21(11):2189–96.CrossRef
112.
Li P, Shan H, Liang S, et al. Sleeve gastrectomy recovering disordered brain function in subjects with obesity: a longitudinal fMRI study. Obes Surg. 2018;28(8):2421–8.PubMedCrossRef
113.
Li G, Ji G, Hu Y, et al. Bariatric surgery in obese patients reduced resting connectivity of brain regions involved with self-referential processing. Hum Brain Mapp. 2018;39(12):4755–65.PubMedPubMedCentralCrossRef
114.
le Roux CW, Aylwin SJ, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg. 2006;243(1):108–14.PubMedPubMedCentralCrossRef
115.
Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg. 2006;93(2):210–5.PubMedCrossRef
116.
Abdeen G, le Roux CW. Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass. Rev Obes Surg. 2016;26(2):410–21.CrossRef
117.
van de Sande-Lee S, Pereira FR, Cintra DE, et al. Partial reversibility of hypothalamic dysfunction and changes in brain activity after body mass reduction in obese subjects. Diabetes. 2011;60(6):1699–704.PubMedPubMedCentralCrossRef
118.
Gazdzinski SP, Gazdzinska AP, Orzel J, et al. Intragastric balloon therapy leads to normalization of brain magnetic resonance spectroscopic markers of diabetes in morbidly obese patients. NMR Biomed. 2018;31(9):e3957.PubMedCrossRef
119.
Dunn JP, Cowan RL, Volkow ND, et al. Decreased dopamine type 2 receptor availability after bariatric surgery: preliminary findings. Brain Res. 2010;1350:123–30.PubMedPubMedCentralCrossRef
120.
Bruce AS, Bruce JM, Ness AR, et al. A comparison of functional brain changes associated with surgical versus behavioral weight loss. Obesity (Silver Spring). 2014;22(2):337–43.CrossRef
Metadata
Title
Legend of Weight Loss: a Crosstalk Between the Bariatric Surgery and the Brain
Authors
Ziwei Lin
Shen Qu
Publication date
01-05-2020
Publisher
Springer US
Published in
Obesity Surgery / Issue 5/2020
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-04474-8

Other articles of this Issue 5/2020

Obesity Surgery 5/2020 Go to the issue

Brief Communication

Fighting Weight Bias and Obesity Stigma: a Call for Action

Original Contributions

Prospective Collection of PROMIS Physical Function Measure Demonstrates Significant Improvement After Bariatric Surgery

Original Contributions

Endoscopic Argon Plasma Coagulation vs. Multidisciplinary Evaluation in the Management of Weight Regain After Gastric Bypass Surgery: a Randomized Controlled Trial with SHAM Group

Original Contributions

Gastric Bypass Improves Obesity and Glucose Tolerance Independent of Gastric Pouch Size

Brief Communication

Endoscopic Repair of Large Gastric Perforation Following Pneumatic Dilation of Sleeve Gastrectomy Stenosis

Original Contributions

Alterations in the Liver Fat Fraction Features Examined by Magnetic Resonance Imaging Following Bariatric Surgery: a Self-Controlled Observational Study